Podcast Episodes
Back to Search
Why INA Solar is growing at 60% but bleeding cash
Insolation Energy (INA.NS) trades at 12x P/E — solar stock buy or sell analysis
👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE…
1 month, 1 week ago
Prosus Trades at a 40 Percent Discount to NAV
Prosus stock analysis: 40% NAV discount reveals massive valuation anomaly — buy or sell
👉 Want this level of research on ANY COMPANY IN THE WORLD... …
1 month, 1 week ago
Bending Spoons BSP: High AI margins meet $4B in debt
BSP stock analysis: 51% operating margins mask a $4.3B debt pile — buy or sell
👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE?…
1 month, 1 week ago
Bending Spoons: The $4B Debt Risk Behind This AI IPO
Bending Spoons (BSP) posts 132% growth — buy or sell stock analysis valuation
👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE? …
1 month, 1 week ago
Rotork ROR: The 38% ROCE Moat the Market Missed
Rotork ROR delivers 38% ROCE — premium industrial stock analysis, valuation buy or sell
👉 Want this level of research on ANY COMPANY IN THE WORLD... …
1 month, 1 week ago
CGEH First Profit in 38 Years Meets a $25M Debt Wall
CGEH stock analysis: Capstone Energy hits first profit in 38 years — buy or sell?
👉 Want this level of research on ANY COMPANY IN THE WORLD... for FR…
1 month, 1 week ago
XRF.AX: The 40% valuation gap the market is ignoring
XRF Scientific (XRF.AX) locks in 68% recurring revenue — buy or sell stock analysis
👉 Want this level of research on ANY COMPANY IN THE WORLD... for …
1 month, 1 week ago
Why JCAP Stock Trades at 6.5x P/E Despite 39% ROE
JCAP stock analysis: trading at 6.5x earnings defies its 27% CAGR — buy or sell
👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE…
1 month, 1 week ago
ACXP Trades Below Cash with a 0% Recurrence Drug
ACXP achieves 0% recurrence in clinical trials — biotech stock analysis and valuation
👉 Want this level of research on ANY COMPANY IN THE WORLD... fo…
1 month, 1 week ago
Why Bakkafrost Is a Rare 50% Discount at NOK 410
Bakkafrost offers 104% target upside — premium salmon stock valuation: buy or sell?
👉 Want this level of research on ANY COMPANY IN THE WORLD... for …
1 month, 1 week ago